These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11045831)

  • 21. Purification and properties of short-chain acyl-CoA, medium-chain acyl-CoA, and isovaleryl-CoA dehydrogenases from human liver.
    Finocchiaro G; Ito M; Tanaka K
    Adv Neurol; 1988; 48():221-30. PubMed ID: 3334784
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of metabolic fluxes of cis-5-enoyl-CoA and saturated acyl-CoA through the beta-oxidation pathway.
    Tserng KY; Chen LS; Jin SJ
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):23-8. PubMed ID: 7717980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid metabolism in riboflavin-deficient rats. 2. Mitochondrial fatty acid oxidation and the microsomal desaturation pathway.
    Olpin SE; Bates CJ
    Br J Nutr; 1982 May; 47(3):589-96. PubMed ID: 7082627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fate of orally ingested 3-phenylpropionic acid.
    Duran M; van Vossen R; Bruinvis L; Ketting D; Dorland L; de Klerk JB
    Prog Clin Biol Res; 1990; 321():419-26. PubMed ID: 2326303
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic effects of carnitine medication in a patient with multiple acyl-CoA dehydrogenation deficiency.
    Gregersen N; Christensen MF; Kølvraa S
    J Inherit Metab Dis; 1985; 8 Suppl 2():139-40. PubMed ID: 3930868
    [No Abstract]   [Full Text] [Related]  

  • 26. Thia fatty acids, metabolism and metabolic effects.
    Skrede S; Sørensen HN; Larsen LN; Steineger HH; Høvik K; Spydevold OS; Horn R; Bremer J
    Biochim Biophys Acta; 1997 Jan; 1344(2):115-31. PubMed ID: 9030189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep.
    Tafti M; Petit B; Chollet D; Neidhart E; de Bilbao F; Kiss JZ; Wood PA; Franken P
    Nat Genet; 2003 Jul; 34(3):320-5. PubMed ID: 12796782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal onset of medium-chain acyl-coenzyme A dehydrogenase deficiency with confusing biochemical features.
    Christodoulou J; Hoare J; Hammond J; Ip WC; Wilcken B
    J Pediatr; 1995 Jan; 126(1):65-8. PubMed ID: 7815228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure and evolution of enzymes involved in fatty acid oxidation].
    Sato S; Kawaguchi A
    Seikagaku; 1996 Nov; 68(11):1692-703. PubMed ID: 8976144
    [No Abstract]   [Full Text] [Related]  

  • 30. Biosynthesis and mitochondrial import of fatty acid oxidation enzymes.
    Mori M; Amaya Y; Arakawa H; Takiguchi M
    Prog Clin Biol Res; 1990; 321():663-72. PubMed ID: 2326321
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduction of beta-oxidation capacity of rat liver mitochondria by feeding orotic acid.
    Miyazawa S; Furuta S; Hashimoto T
    Biochim Biophys Acta; 1982 Jun; 711(3):494-502. PubMed ID: 7104378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome c oxidase deficiency and long-chain acyl coenzyme A dehydrogenase deficiency with Leigh's subacute necrotizing encephalomyelopathy.
    Reichmann H; Scheel H; Bier B; Ketelsen UP; Zabransky S
    Ann Neurol; 1992 Jan; 31(1):107-9. PubMed ID: 1311909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid oxidation defects as causes of unexpected death in infancy.
    Bennett MJ; Allison F; Pollitt RJ; Variend S
    Prog Clin Biol Res; 1990; 321():349-64. PubMed ID: 2326299
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress in Reye syndrome: epidemiology, biochemical mechanisms and animal models.
    Kilpatrick-Smith L; Hale DE; Douglas SD
    Dig Dis; 1989; 7(3):135-46. PubMed ID: 2659225
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and biochemical variation and family studies in the multiple acyl-CoA dehydrogenation disorders.
    Rhead WJ; Wolff JA; Lipson M; Falace P; Desai N; Fritchman K; Moon A; Sweetman L
    Pediatr Res; 1987 Apr; 21(4):371-6. PubMed ID: 3574988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods for the investigation of hypoglycaemia with particular reference to inherited disorders of mitochondrial beta-oxidation.
    Bartlett K
    Baillieres Clin Endocrinol Metab; 1993 Jul; 7(3):643-67. PubMed ID: 8379909
    [No Abstract]   [Full Text] [Related]  

  • 37. MCAD deficiency: what family physicians need to know.
    Siwek J
    Am Fam Physician; 1989 May; 39(5):116, 119. PubMed ID: 2718890
    [No Abstract]   [Full Text] [Related]  

  • 38. Defects of metabolism of fatty acids in the sudden infant death syndrome.
    Howat AJ; Bennett MJ; Variend S; Shaw L; Engel PC
    Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1771-3. PubMed ID: 3924247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
    Schuler AM; Wood PA
    ILAR J; 2002; 43(2):57-65. PubMed ID: 11917157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.
    Willumsen N; Vaagenes H; Lie O; Rustan AC; Berge RK
    Lipids; 1996 Jun; 31(6):579-92. PubMed ID: 8784738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.